NCT02696590View on ClinicalTrials.gov

High Dose Oral Versus Intramuscular Vitamin D3 Supplementation In Multiple Sclerosis Patients

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

December 31, 2015

Conditions
Relapsing Remitting Multiple Sclerosis
Interventions
DIETARY_SUPPLEMENT

Vitamin D3

two forms of vitamin D3 (Oral versus injection) were compared in MS and healthy groups.

Trial Locations (1)

81745319

Alzahra Hospital, Isfahan

All Listed Sponsors
lead

Isfahan University of Medical Sciences

OTHER

NCT02696590 - High Dose Oral Versus Intramuscular Vitamin D3 Supplementation In Multiple Sclerosis Patients | Biotech Hunter | Biotech Hunter